These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 33931929

  • 21. Diagnostic Performance of 68Ga-PSMA-11 PET/CT Versus Multiparametric MRI for Detection of Intraprostatic Radiorecurrent Prostate Cancer.
    Light A, Lazic S, Houghton K, Bayne M, Connor MJ, Tam H, Ahmed HU, Shah TT, Barwick TD.
    J Nucl Med; 2024 Mar 01; 65(3):379-385. PubMed ID: 38212074
    [Abstract] [Full Text] [Related]

  • 22. Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework.
    Reynolds HM, Williams S, Jackson P, Mitchell C, Hofman MS, Hicks RJ, Murphy DG, Haworth A.
    BJU Int; 2019 Jun 01; 123(6):1020-1030. PubMed ID: 30536698
    [Abstract] [Full Text] [Related]

  • 23. Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial.
    Sonni I, Felker ER, Lenis AT, Sisk AE, Bahri S, Allen-Auerbach M, Armstrong WR, Suvannarerg V, Tubtawee T, Grogan T, Elashoff D, Eiber M, Raman SS, Czernin J, Reiter RE, Calais J.
    J Nucl Med; 2022 Jun 01; 63(6):847-854. PubMed ID: 34649942
    [Abstract] [Full Text] [Related]

  • 24. An Update on the Role of mpMRI and 68Ga-PSMA PET Imaging in Primary and Recurrent Prostate Cancer.
    Bagheri H, Mahdavi SR, Geramifar P, Neshasteh-Riz A, Sajadi Rad M, Dadgar H, Arabi H, Zaidi H.
    Clin Genitourin Cancer; 2024 Jun 01; 22(3):102076. PubMed ID: 38593599
    [Abstract] [Full Text] [Related]

  • 25. Gallium-68-prostate-specific membrane antigen (68 Ga-PSMA) positron emission tomography (PET)/computed tomography (CT) predicts complete biochemical response from radical prostatectomy and lymph node dissection in intermediate- and high-risk prostate cancer.
    van Leeuwen PJ, Donswijk M, Nandurkar R, Stricker P, Ho B, Heijmink S, Wit EMK, Tillier C, van Muilenkom E, Nguyen Q, van der Poel HG, Emmett L.
    BJU Int; 2019 Jul 01; 124(1):62-68. PubMed ID: 30074667
    [Abstract] [Full Text] [Related]

  • 26. Prediction of T staging in PI-RADS 4-5 prostate cancer by combination of multiparametric MRI and 68Ga-PSMA-11 PET/CT.
    Ding Y, Mo C, Ding Q, Lin T, Gao J, Chen M, Lu W, Sun J, Wang F, Zang S, Zhang Q, Zhang S, Guo H.
    BMC Urol; 2023 Dec 11; 23(1):206. PubMed ID: 38082379
    [Abstract] [Full Text] [Related]

  • 27. A comparison between 68Ga-labeled prostate-specific membrane antigen-PET/CT and multiparametric MRI for excluding regional metastases prior to radical prostatectomy.
    Frumer M, Milk N, Rinott Mizrahi G, Bistritzky S, Sternberg I, Leibovitch I, Dekel Y, Amiel GE, Zisman A, Baniel J, Haifler M, Gal J, Hoffman A, Sagy I, Rosenzweig B, Haramaty R, Golan S.
    Abdom Radiol (NY); 2020 Dec 11; 45(12):4194-4201. PubMed ID: 32671440
    [Abstract] [Full Text] [Related]

  • 28. Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial.
    Bahler CD, Tachibana I, Tann M, Collins K, Swensson JK, Green MA, Mathias CJ, Tong Y, Yong C, Boris RS, Brocken E, Hutchins GD, Sims JB, Hill DV, Smith N, Ferari C, Love H, Koch MO.
    J Urol; 2024 Aug 11; 212(2):290-298. PubMed ID: 38785259
    [Abstract] [Full Text] [Related]

  • 29. Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database.
    Emmett L, Papa N, Counter W, Calais J, Barbato F, Burger I, Eiber M, Roberts MJ, Agrawal S, Franklin A, Xue A, Rasiah K, John N, Moon D, Frydenberg M, Yaxley J, Stricker P, Wong K, Coughlin G, Gianduzzo T, Kua B, Ho B, Nguyen A, Liu V, Lee J, Hsiao E, Sutherland T, Perry E, Fendler WP, Hope TA.
    J Nucl Med; 2024 Jan 02; 65(1):94-99. PubMed ID: 38050155
    [Abstract] [Full Text] [Related]

  • 30. Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI.
    Freitag MT, Radtke JP, Afshar-Oromieh A, Roethke MC, Hadaschik BA, Gleave M, Bonekamp D, Kopka K, Eder M, Heusser T, Kachelriess M, Wieczorek K, Sachpekidis C, Flechsig P, Giesel F, Hohenfellner M, Haberkorn U, Schlemmer HP, Dimitrakopoulou-Strauss A.
    Eur J Nucl Med Mol Imaging; 2017 May 02; 44(5):776-787. PubMed ID: 27988802
    [Abstract] [Full Text] [Related]

  • 31. 68Ga-PSMA PET/CT better characterises localised prostate cancer after MRI and transperineal prostate biopsy: Is 68Ga-PSMA PET/CT guided biopsy the future?
    Donato P, Morton A, Yaxley J, Ranasinghe S, Teloken PE, Kyle S, Coughlin G, Esler R, Dunglison N, Gardiner RA, Roberts MJ.
    Eur J Nucl Med Mol Imaging; 2020 Jul 02; 47(8):1843-1851. PubMed ID: 31912257
    [Abstract] [Full Text] [Related]

  • 32. Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study.
    Bodar YJL, Zwezerijnen BGJC, van der Voorn PJ, Jansen BHE, Smit RS, Kol SQ, Meijer D, de Bie K, Yaqub M, Windhorst BAD, Hendrikse HNH, Vis AN, Oprea-Lager DE.
    Eur J Nucl Med Mol Imaging; 2022 Apr 02; 49(5):1731-1742. PubMed ID: 34725727
    [Abstract] [Full Text] [Related]

  • 33. Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.
    Yilmaz B, Turkay R, Colakoglu Y, Baytekin HF, Ergul N, Sahin S, Tugcu V, Inci E, Tasci AI, Cermik TF.
    Prostate; 2019 Jun 02; 79(9):1007-1017. PubMed ID: 31012125
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparing the diagnostic value of 68Ga-prostate-specific membrane antigen PET/CT and multiparametric MRI in pelvic lymph node metastasis of locally advanced prostate cancer.
    Xiong Z, Ge Y, Ma S, Wang Y, Li L, Chao Z, Wang X, Sulaiman M, Li C, Luan Y, Yang C, Zeng X, Yu G, Zou S, Zhu X, Wang S, Hu Z, Yang Q, Qin B, Wang Z.
    Transl Androl Urol; 2024 Jul 31; 13(7):1219-1227. PubMed ID: 39100834
    [Abstract] [Full Text] [Related]

  • 36. Combined Utility of 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging in Predicting Prostate Biopsy Pathology.
    Kalapara AA, Ballok ZE, Ramdave S, O'Sullivan R, Ryan A, Konety B, Grummet JP, Frydenberg M.
    Eur Urol Oncol; 2022 Jun 31; 5(3):314-320. PubMed ID: 33741337
    [Abstract] [Full Text] [Related]

  • 37. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Jun 31; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 38. Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.
    Zamboglou C, Drendel V, Jilg CA, Rischke HC, Beck TI, Schultze-Seemann W, Krauss T, Mix M, Schiller F, Wetterauer U, Werner M, Langer M, Bock M, Meyer PT, Grosu AL.
    Theranostics; 2017 Jun 31; 7(1):228-237. PubMed ID: 28042330
    [Abstract] [Full Text] [Related]

  • 39. Can 68 Ga-PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy?
    Khanna Y, Chinni V, Gnanasambantham K, O'Sullivan R, Ballok ZE, Ryan A, Ramdave S, Sivaratnam D, Bowden P, Guerrieri M, Ranasinghe WKB, Frydenberg M.
    BJU Int; 2023 Sep 31; 132(3):321-328. PubMed ID: 37190993
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.